Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - mirtazapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mirtazapine, quantity: 45 mg - tablet, film coated - excipient ingredients: hypromellose; macrogol 8000; magnesium stearate; hyprolose; lactose monohydrate; croscarmellose sodium; microcrystalline cellulose; titanium dioxide - treatment of major depression including relapse prevention

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - mirtazapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - mirtazapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - mirtazapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mirtazapine, quantity: 30 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; lactose monohydrate; titanium dioxide; macrogol 8000; croscarmellose sodium; iron oxide red; microcrystalline cellulose; iron oxide yellow; hyprolose - treatment of major depression including relapse prevention

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - mirtazapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - mirtazapine, quantity: 15 mg - tablet, film coated - excipient ingredients: hypromellose; hyprolose; croscarmellose sodium; titanium dioxide; lactose monohydrate; macrogol 8000; iron oxide yellow; microcrystalline cellulose; magnesium stearate - treatment of major depression including relapse prevention

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - atorvastatin calcium, quantity: 41.44 mg (equivalent: atorvastatin, qty 40 mg) - tablet, film coated - excipient ingredients: povidone; mannitol; methionine; microcrystalline cellulose; crospovidone; sodium carbonate; magnesium stearate; titanium dioxide; hypromellose; macrogol 6000 - atorvastatin is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia.,prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy and alcoholism) should be identified and treated.,hypertensive patients with multiple risk factors for chd which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic chd to reduce the risk of nonfatal mi and nonfatal stroke.,these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - clopidogrel bisulfate (unii: 08i79htp27) (clopidogrel - unii:a74586sno7) - clopidogrel 75 mg - in patients with established peripheral arterial disease or with a history of recent myocardial infarction (mi) or recent stroke clopidogrel bisulfate is indicated to reduce the rate of mi and stroke. clopidogrel bisulfate is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage. clopidogrel bisulfate is contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to clopidogrel or any component of the product [see adverse reactions (6.2)] . pregnancy category b reproduction studies performed in rats and rabbits at doses up to 500 and 300 mg/kg/day, respectively (65 and 78 times the recommended daily human dose, respectively, on a mg/m2 basis), revealed no evidence of impaired fertility or fetotoxicity due to clopidogrel. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of a human response, clopidogrel bisulfate should be used during pregnancy only if cl